News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
131,313 Results
Type
Article (7611)
Company Profile (57)
Press Release (123642)
Multimedia
Podcasts (21)
Webinars (5)
Section
Business (38485)
Career Advice (89)
Deals (5998)
Drug Delivery (10)
Drug Development (23824)
Employer Resources (12)
FDA (3067)
Job Trends (3591)
News (69262)
Policy (4629)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Standard (1)
Academia (331)
Accelerated approval (12)
Adcomms (13)
Allergies (3)
Alliances (11302)
ALS (21)
Alzheimer's disease (162)
Antibody-drug conjugate (ADC) (247)
Approvals (3223)
Artificial intelligence (166)
Autoimmune disease (50)
Automation (5)
Bankruptcy (55)
Best Places to Work (3303)
BIOSECURE Act (1)
Biosimilars (88)
Biotechnology (50)
Bladder cancer (126)
Brain cancer (46)
Breast cancer (480)
Cancer (3478)
Cardiovascular disease (35)
Career advice (82)
Career pathing (5)
CAR-T (123)
CDC (3)
Cell therapy (261)
Cervical cancer (18)
Clinical research (21225)
Collaboration (669)
Company closure (2)
Compensation (210)
Complete response letters (10)
COVID-19 (353)
CRISPR (25)
C-suite (284)
Cystic fibrosis (8)
Data (2234)
Decentralized trials (1)
Denatured (3)
Depression (11)
Diabetes (38)
Diagnostics (1401)
Digital health (6)
Diversity (2)
Diversity, equity & inclusion (5)
Drug discovery (92)
Drug pricing (25)
Drug shortages (1)
Duchenne muscular dystrophy (27)
Earnings (13939)
Editorial (12)
Employer branding (2)
Employer resources (13)
Events (24894)
Executive appointments (314)
FDA (3899)
Fibrodysplasia Ossificans Progressiva (3)
Frontotemporal dementia (2)
Funding (323)
Gene editing (42)
Generative AI (15)
Gene therapy (89)
GLP-1 (126)
Government (489)
Guidances (87)
Healthcare (4069)
HIV (7)
Huntington's disease (3)
IgA nephropathy (17)
Immunology and inflammation (70)
Immuno-oncology (56)
Indications (51)
Infectious disease (390)
Inflammatory bowel disease (35)
Inflation Reduction Act (3)
Influenza (14)
Intellectual property (54)
Interviews (12)
IPO (2992)
IRA (8)
Job creations (484)
Job search strategy (70)
JPM (25)
Kidney cancer (16)
Labor market (8)
Layoffs (139)
Leadership (6)
Legal (477)
Liver cancer (48)
Longevity (1)
Lung cancer (515)
Lymphoma (224)
Machine learning (14)
Management (3)
Manufacturing (132)
MASH (6)
Medical device (876)
Medtech (880)
Mergers & acquisitions (3262)
Metabolic disorders (104)
Multiple sclerosis (15)
NASH (1)
Neurodegenerative disease (30)
Neuropsychiatric disorders (9)
Neuroscience (318)
NextGen: Class of 2026 (957)
Non-profit (509)
Now hiring (17)
Obesity (58)
Opinion (38)
Ovarian cancer (130)
Pain (27)
Pancreatic cancer (164)
Parkinson's disease (31)
Partnered (1)
Patents (90)
Patient recruitment (152)
Peanut (2)
People (13482)
Pharmaceutical (12)
Pharmacy benefit managers (3)
Phase 1 (8016)
Phase 2 (8878)
Phase 3 (6842)
Pipeline (1625)
Policy (33)
Postmarket research (474)
Preclinical (2534)
Press Release (2)
Prostate cancer (168)
Psychedelics (4)
Radiopharmaceuticals (186)
Rare diseases (142)
Real estate (751)
Recruiting (5)
Regulatory (4763)
Reports (8)
Research institute (698)
Resumes & cover letters (11)
RNA editing (2)
RSV (10)
Schizophrenia (36)
Series A (65)
Series B (29)
Service/supplier (1)
Sickle cell disease (37)
Special edition (3)
Spinal muscular atrophy (16)
Sponsored (6)
Startups (766)
State (1)
Stomach cancer (12)
Supply chain (12)
Tariffs (8)
The Weekly (18)
Vaccines (186)
Venture capital (34)
Weight loss (25)
Women's health (5)
Date
Today (5)
Last 7 days (162)
Last 30 days (644)
Last 365 days (8355)
2026 (804)
2025 (8407)
2024 (9468)
2023 (10642)
2022 (13119)
2021 (13189)
2020 (10973)
2019 (8619)
2018 (6344)
2017 (7130)
2016 (6286)
2015 (6966)
2014 (4536)
2013 (3095)
2012 (3346)
2011 (3330)
2010 (3040)
Location
Africa (88)
Alabama (19)
Alaska (1)
Arizona (25)
Arkansas (2)
Asia (11399)
Australia (1538)
California (3098)
Canada (703)
China (589)
Colorado (81)
Connecticut (128)
Delaware (237)
Europe (20768)
Florida (407)
Georgia (12)
Idaho (6)
Illinois (306)
India (18)
Indiana (99)
Iowa (9)
Japan (205)
Kansas (10)
Kentucky (13)
Maine (4)
Maryland (336)
Massachusetts (2453)
Michigan (26)
Minnesota (109)
Missouri (11)
Montana (7)
Nebraska (2)
Nevada (10)
New Hampshire (10)
New Jersey (879)
New Mexico (3)
New York (740)
North Carolina (235)
Northern California (1637)
Ohio (65)
Oklahoma (1)
Oregon (5)
Pennsylvania (460)
Puerto Rico (2)
Rhode Island (6)
South America (119)
South Carolina (3)
Southern California (1220)
Tennessee (36)
Texas (534)
United States (10459)
Utah (75)
Virginia (24)
Washington D.C. (9)
Washington State (291)
Wisconsin (35)
131,313 Results for "mariana oncology".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Novartis Buys Mariana Oncology in $1B Acquisition, Bolsters Radiopharma Assets
The Swiss drugmaker is paying $1 billion and committing up to $750 million in milestones for Mariana Oncology’s preclinical cancer pipeline and clinical supply capabilities, the companies announced Thursday.
May 2, 2024
·
2 min read
·
Nick Paul Taylor
Deals
Mariana Oncology to be Acquired by Novartis to Advance Precision Radiopharmaceuticals to Treat Cancer
Mariana Oncology, a fully integrated biotechnology company pioneering a new era of radiopharmaceutical innovation to treat people with cancer, announced it will be acquired by Novartis for $1 billion upfront and up to $750 million in potential milestone payments.
May 2, 2024
·
3 min read
Genetown
Mariana Oncology Announces $175 Million Series B Financing
Mariana Oncology Inc., a biotechnology company pioneering a new era of radiopharmaceutical innovation to treat cancers with high unmet need, announced the closing of an oversubscribed $175 million Series B financing co-led by Deep Track Capital and Forbion.
September 7, 2023
·
3 min read
Business
Mariana Oncology Expands Management Team, Appoints Linda Bain Chief Operating Officer and Chief Financial Officer
Mariana Oncology today announced the appointment of Linda Bain as Chief Operating Officer and Chief Financial Officer.
May 9, 2023
·
2 min read
Business
Forbion co-leads $175 million Series B financing of Mariana Oncology as first investment of Forbion Ventures Fund VI
Forbion, a leading European life sciences venture capital firm, announces that it has co-led, together with Deep Track Capital, an oversubscribed $175 million Series B financing in Mariana Oncology, the first investment by its Forbion Ventures Fund VI.
September 7, 2023
·
4 min read
Cancer
JPM26: AbbVie Seeks Respect for Oncology Pipeline Following RemeGen Buy
Primarily known as an immunology and neuroscience company, AbbVie wanted to put the biopharma world on notice during its J.P. Morgan presentation: its oncology portfolio is underappreciated. This week, the Illinois-based company dove into the sizzling PD-1/VEGF space with a licensing deal with China-based RemeGen.
January 14, 2026
·
2 min read
·
Heather McKenzie
Job Trends
9 Companies Hiring in Oncology
Looking for a job in oncology? Check out the
BioSpace
list of nine companies hiring life sciences professionals like you.
October 9, 2025
·
2 min read
·
Angela Gabriel
Sponsored
Disruptive Innovation in Cancer Research: The New Era of Oncology
As clinical research evolves, disruptive trial designs are reshaping how oncology advances. By integrating novel methodologies, strategic innovation, and patient-centered approaches, MEDSIR is driving a new era in cancer research, one that accelerates development, enhances efficiency, and delivers more meaningful therapeutic progress for patients worldwide.
December 15, 2025
·
9 min read
Press Releases
Hoth Therapeutics Expands Oncology Pipeline with Dual Patent Filings Establishing Novel Oncology Dermatology IP Platform
January 5, 2026
·
6 min read
Press Releases
Avance Clinical Strengthens Global Oncology Offering with Acquisition of U.S.-Based LumaBridge and Establishes New Oncology Center of Excellence
January 7, 2026
·
3 min read
1 of 13,132
Next